Evidence map›Paper›PMID 36180594›Full record

ArticleNature chemical biology2022

Author Correction: Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine.

Madeline E Kavanagh, Benjamin D Horning, Roli Khattri, Nilotpal Roy, Justine P Lu, Landon R Whitby, Elva Ye, Jaclyn C Brannon, Albert Parker, Joel M Chick and 9 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Probing the proteome.Nature biotechnology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Madeline E Kavanagh *Department of Chemistry, Scripps Research, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4735-1559
Benjamin D Horning *Vividion Therapeutics, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-1772-4489
Roli KhattriVividion Therapeutics, San Diego, CA, USA.
Nilotpal RoyVividion Therapeutics, San Diego, CA, USA.
Justine P LuVividion Therapeutics, San Diego, CA, USA.
Landon R WhitbyVividion Therapeutics, San Diego, CA, USA.
Elva YeDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-7944-4119
Jaclyn C BrannonVividion Therapeutics, San Diego, CA, USA.
Albert ParkerVividion Therapeutics, San Diego, CA, USA.
Joel M ChickVividion Therapeutics, San Diego, CA, USA.
Christie L EisslerVividion Therapeutics, San Diego, CA, USA.
Ashley J WongVividion Therapeutics, San Diego, CA, USA.
Joe L RodriguezVividion Therapeutics, San Diego, CA, USA.
Socorro RodilesVividion Therapeutics, San Diego, CA, USA.
Kim MasudaDepartment of Chemistry, Scripps Research, La Jolla, CA, USA.
John R TeijaroDepartment of Immunology and Microbial Science, Scripps Research, La Jolla, CA, USA.
Gabriel M SimonVividion Therapeutics, San Diego, CA, USA.
Matthew P PatricelliVividion Therapeutics, San Diego, CA, USA. mattp@vividion.com.ORCID http://orcid.org/0000-0002-7829-7065
Benjamin F CravattDepartment of Chemistry, Scripps Research, La Jolla, CA, USA. cravatt@scripps.edu.ORCID http://orcid.org/0000-0001-5330-3492
Vividion Therapeutics (United States) · USScripps Institution of Oceanography · USScripps Research Institute · US

Funding

Wellcome Trust 210890/Z/18/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36180594
OpenAlexW4298140798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.